Depixus in the news

We regularly participate in the world’s leading conferences on tools and technologies for biomolecular analysis and therapeutics. Look out for our presentations and come and say hello to learn more about MAGNA™ and its transformative potential for life sciences research and drug development.

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

Paris, France – Depixus CEO Gordon Hamilton Receives The SLAS2024 Ignite Award From Judge Severine Tamas-Lhoustau, CEO Of Novoptim.

Read More

Depixus appoints  as Chief Commercial Officer to drive the commercialization of its groundbreaking MAGNA™ technology

PARIS, France – Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its first laboratory instrument, MAGNA One™, in 2024.

Read More

Depixus launches technology access program with first MAGNA One™ instrument placement

PARIS, France – Interactomics pioneer Depixus has launched its game-changing MAGNA technology access program with the deployment of the first ‘MAGNA One’ beta prototype instrument in the laboratory of Professor Jean-François Allemand, Department of Physics at the École Normale Supérieure (ENS), Paris.

Read More